SPAIN | ACTIS
06/11/2019
Límite 19 Oct 2022
Oferta Tecnológica
Ref.
TODE20211014002
A 3D-printed biomimetic tumour angiogenesis model
A German university offers a model that can be used to analyse tumour growth, tumour angiogenesis and therapeutic effects on a 3D-printed cell model. No animal tissue is needed. Therefore, this 3D-printed tumour model represents an ideal in-vitro-prescreening system for testing pharmaceuticals and diagnostics and might be able to circumvent or at least reduce the number of animal tests in drug development. Licensees are sought.
Socios

logotipo CEOE Aragónlogotipo ITAlogotipo Cámara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

27/02/2024

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019